The role of FSH and TSH in bone loss and its clinical relevance

Current Osteoporosis Reports

Volumn 8, Issue 4, 2010, Pages 205-211

  Agrawal, Manasi ^a   Zhu, Guangyu ^a   Sun, Li ^a   Zaidi, Mone ^a   Iqbal, Jameel ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bone loss; Estrogen; FSH; Menopause; Osteoclast; Osteoporosis; TSH

Indexed keywords

ESTROGEN; FOLLITROPIN; LEVOTHYROXINE; OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT THYROTROPIN; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE;

AMENORRHEA; BONE DENSITY; BONE MASS; BONE TURNOVER; CELL ACTIVITY; CLIMACTERIUM; COMPUTER ASSISTED TOMOGRAPHY; DRUG INTERMITTENT THERAPY; EARLY DIAGNOSIS; GOITER; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; REVIEW; THYROID CANCER; THYROID DISEASE; THYROID NODULE; THYROTROPIN BLOOD LEVEL;

ANIMALS; BONE DENSITY; BONE REMODELING; FOLLICLE STIMULATING HORMONE; HUMANS; OSTEOBLASTS; OSTEOPOROSIS; PERIMENOPAUSE; THYROTROPIN;

EID: 77958102223     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-010-0028-x     Document Type: Review

References (64)

1. L Sun Y Peng AC Sharrow, et al. 2006 FSH directly regulates bone mass Cell 125 247 260 1:CAS:528:DC%2BD28Xkt1Oqtbs%3D 10.1016/j.cell.2006.01.051 16630814
2. MR Sowers GA Greendale I Bondarenko, et al. 2003 Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN Osteoporos Int 14 191 197 1:CAS:528:DC%2BD3sXlslOls7k%3D 10.1007/s00198-002-1307-x 12730778 (Pubitemid 36267900)
3. MP Akhter JM Lappe KM Davies RR Recker 2007 Transmenopausal changes in the trabecular bone structure Bone 41 111 116 1:STN:280:DC%2BD2szls1ensQ%3D%3D 10.1016/j.bone.2007.03.019 17499038 (Pubitemid 46891901)
4. R Recker J Lappe KM Davies R Heaney 2004 Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients J Bone Miner Res 19 1628 1633 10.1359/JBMR.040710 15355557 (Pubitemid 41094325)
5. DS Ross 1994 Hyperthyroidism, thyroid hormone therapy, and bone Thyroid 4 319 326 1:STN:280:DyaK2M7jsFWgsw%3D%3D 10.1089/thy.1994.4.319 7833670
6. DT Baran 1994 Thyroid hormone and bone mass: the clinician's dilemma Thyroid 4 143 144 1:STN:280:DyaK2M%2FgtlOitg%3D%3D 10.1089/thy.1994.4.143 7919994
7. E Abe RC Marians W Yu 2003 Wu et al.: TSH is a negative regulator of skeletal remodeling Cell 115 151 162 1:CAS:528:DC%2BD3sXosFCqsL4%3D 10.1016/S0092-8674(03)00771-2 14567913 (Pubitemid 37329579)
8. A Imam J Iqbal HC Blair, et al. 2009 Role of the pituitary-bone axis in skeletal pathophysiology Curr Opin Endocrinol Diabetes Obes 16 423 429 1:CAS:528:DC%2BD1MXhtlegu7vE 19816170 This articles shows insights into a recently identified endocrine pathway of bone metabolism regulation
9. Y Wu J Torchia W Yao, et al. 2007 Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency PLoS One 2 e586 10.1371/journal.pone.0000586 17611621
10. J Gao R Tiwari-Pandey R Samadfam, et al. 2007 Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone Endocrinology 148 2613 2621 1:CAS:528:DC%2BD2sXmt1ajtrs%3D 10.1210/en.2006-1404 17332067 (Pubitemid 46984812)
11. JG Cannon M Cortez-Cooper E Meaders, et al. 2010 Follicle-stimulating hormone, interleukin-1, and bone density in adult women Am J Physiol Regul Integr Comp Physiol 298 R790 R798 1:CAS:528:DC%2BC3cXjsFGnt7k%3D 20042686
12. J Iqbal L Sun TR Kumar, et al. 2006 Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation Proc Natl Acad Sci U S A 103 14925 14930 1:CAS:528:DC%2BD28XhtVygsrjJ 10.1073/pnas.0606805103 17003115 (Pubitemid 44527830)
13. D Rendina F Gianfrancesco G De Filippo, et al. 2010 FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women Eur J Endocrinol 163 165 172 1:CAS:528:DC%2BC3cXpsFeisrc%3D 10.1530/EJE-10-0043 20335500
14. CJ Jagger JW Chow TJ Chambers 1996 Estrogen suppresses activation but enhances formation phase of osteogenic response to mechanical stimulation in rat bone J Clin Invest 98 2351 2357 1:CAS:528:DyaK28XntVOhsbg%3D 10.1172/JCI119047 8941653
15. NK Shevde AC Bendixen KM Dienger JW Pike 2000 Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression Proc Natl Acad Sci U S A 97 7829 7834 1:CAS:528:DC%2BD3cXkvFCntb8%3D 10.1073/pnas.130200197 10869427 (Pubitemid 30460733)
16. S Srivastava G Toraldo MN Weitzmann, et al. 2002 Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation J Biol Chem 276 8836 8840 10.1074/jbc.M010764200
17. S Srivastava MN Weitzmann RB Kimble, et al. 1998 Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1 J Clin Invest 102 1850 1859 1:CAS:528: DyaK1cXns1Omsrw%3D 10.1172/JCI4561 9819371
18. MR Sowers M Jannausch D McConnell, et al. 2006 Hormone predictors of bone mineral density changes during the menopausal transition J Clin Endocrinol Metab 91 1261 1267 1:CAS:528:DC%2BD28XjvFOks7k%3D 10.1210/jc.2005-1836 16403818
19. B Devleta B Adem S Senada 2004 Hypergonadotropic amenorrhea and bone density: new approach to an old problem J Bone Miner Metab 22 360 364 10.1007/s00774-004-0495-1 15221495
20. MR Sowers H Zheng ML Jannausch, et al. 2010 Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause J Clin Endocrinol Metab 95 2155 2162 1:CAS:528:DC%2BC3cXmtFegurg%3D 10.1210/jc.2009-0659 20215399 This article provides further evidence of bone loss during perimenopause, substantiating the role of FSH further, with significant clinical implications
21. ZR Xu AH Wang XP Wu, et al. 2009 Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women Clin Chim Acta 400 8 13 1:CAS:528:DC%2BD1MXht1GlsA%3D%3D 10.1016/j.cca.2008.09.027 18930719
22. XY Wu XP Wu H Xie, et al. 2010 Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women Osteoporos Int 21 275 285 1:CAS:528:DC%2BC3cXjtl2nsg%3D%3D 10.1007/s00198-009-0943-9 19562242
23. S Liu Y Cheng M Fan, et al. 2010 FSH aggravates periodontitis-related bone loss in ovariectomized rats J Dent Res 89 366 371 1:CAS:528: DC%2BC3cXltV2ntrg%3D 10.1177/0022034509358822 20139335
24. S Liu Y Cheng W Xu Z Bian 2010 Protective effects of follicle-stimulating hormone inhibitor on alveolar bone loss resulting from experimental periapical lesions in ovariectomized rats J Endod 36 658 663 10.1016/j.joen.2010.01.011 20307740
25. CM Gallagher BS Moonga JS Kovach 2010 Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III Environ Res 110 105 111 1:CAS:528:DC%2BD1MXhsFGgtLnL 10.1016/j.envres.2009.09.012 19875111
26. C Castelo-Branco M León M Durán J Balasch 2008 Follicle-stimulating hormone does not directly regulate bone mass in human beings: evidence from nature Fertil Steril 90 2211 2216 1:CAS:528: DC%2BD1MXmtlOqug%3D%3D 10.1016/j.fertnstert.2007.10.040 18191857
27. PD Miller 2006 Guidelines for the diagnosis of osteoporosis: T-scores vs fractures Rev Endocr Metab Disord 7 75 89 10.1007/s11154-006-9006-0 17186388 (Pubitemid 46044350)
28. XS Liu P Sajda PK Saha, et al. 2006 Quantification of the roles of trabecular microarchitecture and trabecular type in determining the elastic modulus of human trabecular bone J Bone Miner Res 21 1608 1617 10.1359/jbmr.060716 16995816 (Pubitemid 44484606)
29. PR Ebeling LM Atley JR Guthrie, et al. 1996 Bone turnover markers and bone density across the menopausal transition J Clin Endocrinol Metab 81 3366 3371 1:CAS:528:DyaK28Xls1OrtLk%3D 10.1210/jc.81.9.3366 8784098 (Pubitemid 26296217)
30. RD Chapurlat P Garnero E Sornay-Rendu, et al. 2000 Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women Osteoporos Int 11 493 498 1:STN:280:DC%2BD3cvotFSiuw%3D%3D 10.1007/s001980070091 10982164
31. CJ Rosen CH Chesnut 3rd 1997 Mallinak NJ: The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation J Clin Endocrinol Metab 82 1904 1910 1:CAS:528:DyaK2sXjs1ent7Y%3D 10.1210/jc.82.6.1904 9177404
32. E Murphy GR Williams 2004 The thyroid and the skeleton Clin Endocrinol (Oxf) 61 285 298 1:CAS:528:DC%2BD2cXpsVSitro%3D 10.1111/j.1365-2265.2004.02053.x (Pubitemid 39287057)
33. KW Wenzel 1994 Thyroid hormone and bone Thyroid 4 508 509 1:STN:280:DyaK2M3is12huw%3D%3D 10.1089/thy.1994.4.508 7711517
34. TJ Allain TJ Chambers AM Flanagan AM McGregor 1992 Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect J Endocrinol 133 327 331 1:CAS:528:DyaK38XisV2jtL4%3D 10.1677/joe.0.1330327 1613434
35. JM Britto AJ Fenton WR Holloway GC Nicholson 1994 Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption Endocrinology 134 169 176 1:CAS:528:DyaK2cXps1Gmtw%3D%3D 10.1210/en.134.1.169 8275930 (Pubitemid 24021985)
36. CH Kim HK Kim YK Shong, et al. 1999 Thyroid hormone stimulates basal and interleukin (IL)-1-induced IL-6 production in human bone marrow stromal cells: a possible mediator of thyroid hormone-induced bone loss J Endocrinol 160 97 102 1:CAS:528:DyaK1MXjs12kuro%3D 10.1677/joe.0.1600097 9854181 (Pubitemid 29044572)
37. Y Ishikawa BR Genge RE Wuthier LN Wu 1998 Thyroid hormone inhibits growth and stimulates terminal differentiation of epiphyseal growth plate chondrocytes J Bone Miner Res 13 1398 1411 1:CAS:528:DyaK1cXmtVeqtb8%3D 10.1359/jbmr.1998. 13.9.1398 9738512 (Pubitemid 28418906)
38. JH Bassett K Nordström A Boyde, et al. 2007 Thyroid status during skeletal development determines adult bone structure and mineralization Mol Endocrinol 21 1893 1904 1:CAS:528:DC%2BD2sXos12rsrk%3D 10.1210/me.2007-0157 17488972 (Pubitemid 47173799)
39. JM Kindblom EF Gevers SM Skrtic, et al. 2005 Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors Bone 36 607 616 1:CAS:528:DC%2BD2MXjs1KrtLo%3D 10.1016/j.bone.2005. 01.017 15780976 (Pubitemid 40602254)
40. S Göthe Z Wang L Ng, et al. 1999 Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation Genes Dev 13 1329 1341 10.1101/gad.13.10.1329 10346821
41. DC Bauer B Ettinger MC Nevitt 2001 Stone KL; Study of osteoporotic fractures research group: risk for fracture in women with low serum levels of thyroid-stimulating hormone Ann Intern Med 134 561 568 1:CAS:528: DC%2BD3MXivVaju7c%3D 12803168
42. MS Morris 2007 The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women Bone 40 1128 1134 1:CAS:528:DC%2BD2sXjtVaksbY%3D 10.1016/j.bone.2006.12.001 17236836 (Pubitemid 46386560)
43. DV Novack 2003 TSH, the bone suppressing hormone Cell 115 129 130 1:CAS:528:DC%2BD3sXosFCqs7s%3D 10.1016/S0092-8674(03)00812-2 14567908 (Pubitemid 37329574)
44. M Zaidi L Sun TF Davies E Abe 2006 Low TSH triggers bone loss: fact or fiction? Thyroid 16 1075 1076 1:CAS:528:DC%2BD28Xht1CgtbvP 10.1089/thy.2006.16. 1075 17123332 (Pubitemid 44864481)
45. H Hase T Ando L Eldeiry, et al. 2006 TNFalpha mediates the skeletal effects of thyroid-stimulating hormone Proc Natl Acad Sci U S A 103 12849 12854 1:CAS:528:DC%2BD28XptVymtrk%3D 10.1073/pnas.0600427103 16908863 (Pubitemid 44298650)
46. L Sun S Vukicevic R Baliram, et al. 2008 Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss Proc Natl Acad Sci U S A 105 4289 4294 1:CAS:528:DC%2BD1cXktF2gsrY%3D 10.1073/pnas.0712395105 18332426 This article provides deeper insight into mechanisms of bone loss, with significant clinical ramifications (Pubitemid 351754373)
47. K Yamoah A Brebene R Baliram, et al. 2008 High-mobility group box proteins modulate tumor necrosis factor-alpha expression in osteoclastogenesis via a novel deoxyribonucleic acid sequence Mol Endocrinol 22 1141 1153 1:CAS:528:DC%2BD1cXlsVSru7o%3D 10.1210/me.2007-0460 18218727 (Pubitemid 351629614)
48. Ma R, Latif R, Zaidi M, Davies T: Thyroid and Bone: TSH inhibits osteoclastogenesis from embryonic stem cells. Presented at the 91st Annual Meeting of the Endocrine Society. Washington, DC; June 10-13, 2009.
49. TK Sampath P Simic R Sendak, et al. 2007 Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats J Bone Miner Res 22 849 859 1:CAS:528:DC%2BD2sXpt12jtr8%3D 10.1359/jbmr.070302 17352644 (Pubitemid 351339745)
50. G Mazziotti F Sorvillo M Piscopo, et al. 2005 Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma J Bone Miner Res 20 480 486 1:CAS:528:DC%2BD2MXis1Knu7Y%3D 10.1359/JBMR.041126 15746993 (Pubitemid 40293497)
51. M Giusti F Cecoli C Ghiara, et al. 2007 Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma Hormones (Athens) 6 304 313
52. G Martini L Gennari V De Paola, et al. 2008 The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels Thyroid 18 455 460 1:CAS:528:DC%2BD1cXksFynsrg%3D 10.1089/thy.2007.0166 18399769 (Pubitemid 351519539)
53. I Zofkova M Hill 2008 Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women Endocr Regul 42 121 127 1:CAS:528:DC%2BD1cXhtlyjtb%2FL 18999899
54. S La Vignera E Vicari S Tumino, et al. 2008 L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history Minerva Ginecol 60 475 484 18981975
55. RW Flynn SR Bonellie RT Jung, et al. 2010 Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy J Clin Endocrinol Metab 95 186 193 1:CAS:528:DC%2BC3cXhtVGhsL0%3D 10.1210/jc.2009-1625 19906785
56. L Baqi J Payer Z Killinger, et al. 2010 The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women Endocr Regul 44 9 15 1:CAS:528:DC%2BC3cXms1CmtL4%3D 10.4149/endo-2010-01-9 20151763
57. G Grimnes N Emaus RM Joakimsen, et al. 2008 The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromsø study Thyroid 18 1147 1155 1:CAS:528:DC%2BD1cXhsVagt7fF 10.1089/thy.2008.0158 18925834
58. P Mikosch K Kerschan-Schindl W Woloszczuk, et al. 2008 High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy Thyroid 18 27 33 1:CAS:528:DC%2BD1cXht1Sit74%3D 10.1089/thy.2007.0186 18302515 (Pubitemid 351170452)
59. A Svare TI Nilsen T Bjøro, et al. 2009 Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study Eur J Endocrinol 161 779 786 1:CAS:528:DC%2BD1MXhsFajtL7O 10.1530/EJE-09-0139 19671706
60. M Nagata A Suzuki S Sekiguchi, et al. 2007 Subclinical hypothyroidism is related to lower heel QUS in postmenopausal women Endocr J 54 625 630 1:CAS:528:DC%2BD2sXhtlaqs7%2FE 10.1507/endocrj.K06-201 17641439 (Pubitemid 47414613)
61. G Mazziotti T Porcelli I Patelli, et al. 2010 Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density Bone 46 747 751 1:CAS:528:DC%2BC3cXitV2gsb0%3D 10.1016/j.bone.2009.10. 031 19892039
62. KA Heemstra WM van der Deure RP Peeters, et al. 2008 Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma Eur J Endocrinol 159 69 76 1:CAS:528:DC%2BD1cXotlKiurs%3D 10.1530/EJE-08-0038 18390987 (Pubitemid 351969133)
63. WM van der Deure AG Uitterlinden A Hofman, et al. 2008 Effects of serum TSH and FT4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study Clin Endocrinol (Oxf) 68 175 181
64. OME Albagha R Natarajan DM Reid, et al. 2005 The D272E polymorphism of the human thyroid stimulating hormone receptor is associated with bone mineral density and bone loss in women from UK [abstract M115] J Bone Miner Res 20 Suppl 1 S341